E2A-HLF Fusion Transcription Factor Mediating Aberrant Expression of LMO2 in B-Precursor ALL with t(17;19).
Kinuko Hirose(University of Yamanashi), Kanji Sugita(University of Yamanashi), Itaru Kuroda(University of Yamanashi), Takeshi Inukai(University of Yamanashi), Koshi Akahane(University of Yamanashi), A. Thomas Look(Dana-Farber Cancer Institute), Shinpei Nakazawa(University of Yamanashi), Xiaochun Zhang(Qingdao University), Kumiko Goi(St. Jude Children's Research Hospital), Hiroko Honna(University of Yamanashi), Toshiya Inaba(Hiroshima University)
Cited by 0
Related Papers
Acute lymphoblastic leukaemia
|The Lancet|2008|1.6k
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
|Cancer Cell|2002|1.1k
<i>FBW7</i> mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors
|The Journal of Experimental Medicine|2007|660
Resolution of inflammation by retrograde chemotaxis of neutrophils in transgenic zebrafish
|Journal of Leukocyte Biology|2006|527